Sign in
CTXR Stock Price, Chart, Stats & News
Citius Pharmaceuticals, Inc.
Save
Citius Pharmaceuticals, Inc. (CTXR) does not currently pay a dividend.
15.30M
Market cap
–
Current P/E
0.32x
Forward P/E
CTXR chart
Fundamentals
Gross margin | 61.41% |
Operating margin | -950.92% |
Pretax margin | -958.29% |
Net margin | -909.87% |
Effective tax rate | -2.80% |
ROA | -25.56% |
ROE | -52.54% |
D/E | 0.02x |
Interest coverage ratio | -88.60x |
CTXR valuation
P/E | – |
P/S | 2.04x |
P/B | 0.19x |
P/CF | -0.44x |
P/FCF | -0.23x |
P/OCF | -0.44x |
PEG | -0.02x |
EV multiple | -0.38x |
About
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures.
Similar securities
Based on sector and market capitalization
Report issue